Other Events ·
Admits 11,948 further ordinary shares to trading on the London Stock Exchange Main Market
AZNAstrazeneca PLC
AstraZeneca PLC admitted 11,948 additional ordinary shares ($0.25 par value) to trading on the Main Market of the London Stock Exchange. These securities were issued between October 1 and October 31, 2026, under an existing block admission dated January 29, 2021. The total number of ordinary shares in issue following this admission stands at 1,551,065,237. The filing serves as a regulatory notification pursuant to the Public Offers and Admissions to Trading Regulations 2024 regarding routine employee share scheme issuances. AstraZeneca PLC is a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines in oncology, rare disease, and biotherapeutics.